Fidelity Management & Research Co has recently announced that it has increased stake in LifeStance Health Group Inc (NASDAQ:LFST) by 7.47%. After grabbing 24.92 million shares, the institutional investor is now in possession of 1.73 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.59% having worth around $145.27 million. Moreover, The Vanguard Group, Inc. increased its share by 81291.0 to have a control over 7.32 million shares. And Brown Advisory LLC raised its holdings to 4.1 million shares by acquiring 4.1 million shares or 1.08% of the stake.
LifeStance Health Group Inc (LFST) concluded trading on 12/06/23 at a closing price of $6.65, with 5.17 million shares of worth about $34.36 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.39% during that period and on Wednesday the price saw a gain of about 2.62%. Currently the company’s common shares owned by public are about 375.96M shares, out of which, 73.12M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 7 analysts are covering the LFST stock and their offered price forecasts bring an average price target of $7.83. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $10.00 and could fall to a lowest price of $6.00. The stock’s current price level is 15.07% above of average price target set by the analysts, while a rise to estimated low would result in loss of -10.83% for the stock. However, touching the estimated high of $10.00 would mean a gain of 33.5% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 45 times over the past 12 months. They bought 3,858,981 shares in 14 of the transactions. In 31 selling transactions, insiders dumped 1,341,168 shares.
Fidelity Select Medical Technolog, Fidelity Select Port. – Health Ca, and Fidelity Advisor Health Care Fund are the top 3 mutual funds which are holding stakes in LifeStance Health Group Inc Fidelity Select Medical Technolog is currently holding 6.4 million shares of worth totaling $37.31 million. The company recently came buying 0.0 shares which brought its stake up to 1.69% of the company’s outstanding shares. Fidelity Advisor Health Care Fund, after buying 4.0 million shares, have now control over 1.06% of the stake in the company. It holds 0.0 shares of worth $23.32 million.
LifeStance Health Group Inc (NASDAQ: LFST) started trading at $6.55, above $0.07 from concluding price of the previous day. However, the stock later moved at a day high price of 6.72, or with a gain of 2.62%. Stock saw a price change of -1.48% in past 5 days and over the past one month there was a price change of 13.29%. Year-to-date (YTD), LFST shares are showing a performance of 34.62% which increased to 17.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.22 but also hit the highest price of $9.59 during that period. The average intraday trading volume for LifeStance Health Group Inc shares is 852.02K. The stock is currently trading 6.06% above its 20-day simple moving average (SMA20), while that difference is up 7.42% for SMA50 and it goes to -10.19% lower than SMA200.
Fidelity Management & Research Co acquired 24.92 million shares of LifeStance Health Group Inc having value of about $145.27 million. Data submitted at the U.S SEC by Fidelity Management & Research Co revealed that the firm now holds 1.73 million shares in the company valued at close to $11519429.25, or have control over 7.47% stake in the company. LifeStance Health Group Inc (NASDAQ: LFST) currently have 375.96M outstanding shares and institutions hold larger chunk of about 20.85% of that. Holding of mutual funds in the company is about 64.77% while other institutional holders and individual stake holders have control over 8.01% and 12.88% of the stake respectively.
The stock has a current market capitalization of $2.52B and its 3Y-monthly beta is at 1.20. It has posted earnings per share of -$0.51 in the same period. It has Quick Ratio of 1.10 while making debt-to-equity ratio of 0.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LFST, volatility over the week remained 4.78% while standing at 4.84% over the month.
Analysts are in expectations that LifeStance Health Group Inc (LFST) stock would likely to be making an EPS of -$0.08 in the current quarter, while forecast for next quarter EPS is -$0.1 and it is -$0.27 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.1 which is -$0.07 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.13 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 22.85% while it is estimated to increase by 40.59% in next year.
Analysts at 7 brokerage firms have issued recommendations for the LifeStance Health Group Inc (LFST)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.14. Out of those 7 Wall Street analysts, 3 recommended a “Buy” rating, while 4 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by TD Cowen on May 15, 2023 offering a Market perform rating for the stock and assigned a target price range of between $8 and $9 to it.
